Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2/3 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Endometrial Neoplasms 1Endometrial Hyperplasia 1Breast Neoplasms 1

Interventions

Cyclophosphamide 2067Radiotherapy 1986Cisplatin 1855Carboplatin 1559Gemcitabine 1454Paclitaxel 1320Bevacizumab 1318pembrolizumab 1236Docetaxel 1227Oxaliplatin 1184Capecitabine 1176Fluorouracil 1083Dexamethasone 978Magnetic Resonance Spectroscopy 969Nivolumab 936Rituximab 929Drug Therapy 914Surveys and Questionnaires 898Doxorubicin 845Etoposide 843Radiosurgery 815Blood Specimen Collection 815Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 639Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × ricin A-GnRH conjugate × Clear all
NCT03463252 2021-09-13

Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC

West China Second University Hospital

Phase 2/3 Recruiting
224 enrolled
Gynecologic

Endometrial Hyperplasia, Endometrial Neoplasms

NCT03954197 2019-05-20

PRIMIV

Hôpital Jean Verdier

Phase NA Unknown
204 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡